trending Market Intelligence /marketintelligence/en/news-insights/trending/yTVL_HfMD8RYjFVRHgjvew2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Healthcare segment performance boosts Aetna's Q2 income

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report

Fintech

Fintech Funding Flows To Insurtech In February

Lemonade Growing Premiums Faster Than Esurance's Homeowners Business Did


Healthcare segment performance boosts Aetna's Q2 income

Aetna Inc. reported second-quarter GAAP net income of $1.20 billion, or $3.60 per share, compared to $791 million, or $2.23 per share, in the year-ago quarter.

Adjusted earnings for the quarter were $1.15 billion, or $3.42 per share, up from $783 million, or $2.21 per share, in the year-ago quarter.

The S&P Capital IQ consensus normalized EPS estimate for the quarter was $2.35.

The increase in adjusted earnings resulted from the continued strong performance in Aetna's healthcare segment. The increase also reflects a larger decrease in the company's estimate of risk adjustment payables for the prior year for its individual and small group Affordable Care Act-compliant products in the most recent quarter compared to the year-ago period.

Total revenues declined 3% year over year to $15.52 billion from $15.95 billion. Adjusted revenue totaled $15.50 billion, down from $15.90 billion a year ago. The decrease in total and adjusted revenues was primarily due to lower premiums in the healthcare segment, including lower membership in ACA-compliant individual and small group products, and the temporary suspension of the health insurer fee in 2017.

The total healthcare medical benefit ratio for the most recent quarter was 80.0%, compared to 82.4% in the year-ago quarter. The commercial medical benefit ratio was 78.6%, versus 83.4% a year ago, and the second-quarter government medical benefit ratio was 81.3% compared to 81.4% in the second quarter of 2016.

Total medical membership was 22.1 million at June 30, compared to 22.4 million at March 31, and 23.0 million at June 30, 2016.

For full year 2017, Aetna expects net income per share of $5.46 to $5.56. Adjusted EPS is expected to be between $9.45 to $9.55. The company previously expected net income per share to be between $4.48 and $4.68, and adjusted EPS of $8.80 to $9.00.

The S&P Capital IQ consensus normalized EPS estimate for 2017 is $8.99.